The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 30, 2010

Filed:

Aug. 16, 2006
Applicants:

Chad E. Bennett, Metuchen, NJ (US);

William J. Greenlee, Teaneck, NJ (US);

Chad E. Knutson, Garwood, NJ (US);

Duane A. Burnett, Bernardsville, NJ (US);

Inventors:

Chad E. Bennett, Metuchen, NJ (US);

William J. Greenlee, Teaneck, NJ (US);

Chad E. Knutson, Garwood, NJ (US);

Duane A. Burnett, Bernardsville, NJ (US);

Assignee:

Schering Corporation, Kenilworth, NJ (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07D 495/14 (2006.01); C07D 417/14 (2006.01); A61K 31/4985 (2006.01); C07D 213/85 (2006.01); C07D 495/04 (2006.01); C07D 239/30 (2006.01); C07D 239/58 (2006.01); A61P 25/06 (2006.01); A61P 25/04 (2006.01); A61P 25/22 (2006.01); A61P 25/28 (2006.01);
U.S. Cl.
CPC ...
Abstract

In its many embodiments, the present invention provides tricyclic compounds of formula I (wherein J-J, X, Z, and R, R, and Rare as defined herein) useful as metabotropic glutamate receptor (mGluR) antagonists, particularly as selective metabotropic glutamate receptor 1 antagonists, pharmaceutical compositions containing the compounds, and methods of treatment using the compounds and compositions to treat diseases associated with metabotropic glutamate receptor (e.g., mGluR1) such as, for example, pain, migraine, anxiety, urinary incontinence and neurodegenerative diseases such Alzheimer's disease.


Find Patent Forward Citations

Loading…